Increased PEDF may act as a protective response against vascular damage and subsequent CAD [42], and there is convincing evidence suggesting that the risk of a clinical event independently and gradually elevates with increasing concentrations of PEDF in patients with advanced HF [14]. The gene discussed is SERPINF1; the disease is coronary artery disorder.